Nivolumab plus docetaxel in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer: results from the phase II CheckMate 9KD trial

  1. Fizazi, K.
  2. González Mella, P.
  3. Castellano, D.
  4. Minatta, J.N.
  5. Rezazadeh Kalebasty, A.
  6. Shaffer, D.
  7. Vázquez Limón, J.C.
  8. Sánchez López, H.M.
  9. Armstrong, A.J.
  10. Horvath, L.
  11. Bastos, D.A.
  12. Amin, N.P.
  13. Li, J.
  14. Unsal-Kacmaz, K.
  15. Retz, M.
  16. Saad, F.
  17. Petrylak, D.P.
  18. Pachynski, R.K.
Revista:
European Journal of Cancer

ISSN: 1879-0852,  0959-8049

Any de publicació: 2022

Volum: 160

Pàgines: 61-71

Tipus: Article

DOI: 10.1016/J.EJCA.2021.09.043 GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus